id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S3852 R8207 |
Huybrechts, 2019 | Cardiac malformations | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Intravenous | 0.97 [0.86;1.10] | -/23,866 -/1,762,018 | - | 23,866 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2757 R3713 |
Zambelli-Weiner (Unexposed control, NOS), 2019 | Cardiac Defects | 1st trimester | nested case control | unexposed (general population or NOS) excluded | Adjustment: Yes |
1.43 [1.28;1.61] excluded (control group) |
303/1,181 29,001/142,107 | 29,304 | 1,181 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3041 R4609 |
Zambelli-Weiner (Unexposed control, sick), 2019 | Cardiac defects | 1st trimester | nested case control | unexposed, sick | Adjustment: Yes | 1.48 [1.14;1.92] | 303/- 29,001/- | 29,304 | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2852 R3860 |
Huybrechts (Control exposed to other treatment), 2018 | Cardiac malformations | 1st trimester | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: Yes |
1.01 [0.92;1.12] excluded (control group) |
518/55,579 1,628/185,699 | 2,146 | 55,579 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2844 R3814 |
Huybrechts (Unexposed control), 2018 | Cardiac malformations | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes | 0.99 [0.93;1.06] | 835/88,446 14,573/1,727,546 | 15,408 | 88,446 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2778 R3783 |
Fejzo (Mainly exposed to other treatements, sick), 2016 | Heart Defect | 1st trimester | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
5.12 [0.28;92.79] C excluded (control group) |
5/952 0/441 | 5 | 952 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2776 R3745 |
Fejzo (Unexposed control, disease free), 2016 | Heart defects | 1st trimester | retrospective cohort | unexposed, disease free | Adjustment: No | 0.84 [0.28;2.59] C | 5/952 8/1,286 | 13 | 952 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2752 R3661 |
Danielsson, 2014 | Cardiovascular defect | early pregnancy | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes | 1.62 [1.04;2.54] | 19/1,349 14,872/1,501,434 | 14,891 | 1,349 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2753 R3672 |
Andersen, 2013 | Heart defects | 1st trimester | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes | 2.00 [0.30;3.10] | -/1,248 -/895,770 | - | 1,248 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 6 studies | 1.13 [0.96;1.33] | 59,616 | 115,861 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Unexposed control, sick; 2: Unexposed control; 3: Unexposed control, disease free;
Asymetry test p-value = 0.1557 (by Egger's regression)
slope=-0.0598 (0.0586); intercept=1.4674 (0.8403); t=1.7464; p=0.1557
excluded 2778, 2852, 2757